🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/11/2018 | 115,75 | 117,17 | 113,02 | 114,64 | -0,35% | 3,59% | 388.200 |
| 01/11/2018 | 110,78 | 115,24 | 110,18 | 115,04 | +3,77% | 4,57% | 670.700 |
| 31/10/2018 | 118,37 | 125,70 | 109,82 | 110,86 | -9,63% | 13,42% | 806.500 |
| 30/10/2018 | 117,81 | 122,85 | 117,56 | 122,67 | +4,25% | 4,49% | 385.900 |
| 29/10/2018 | 119,92 | 121,23 | 115,64 | 117,67 | -0,61% | 4,66% | 313.900 |
| 26/10/2018 | 117,97 | 119,87 | 115,23 | 118,39 | -0,47% | 3,93% | 379.200 |
| 25/10/2018 | 116,84 | 120,36 | 115,51 | 118,95 | +2,43% | 4,15% | 350.500 |
| 24/10/2018 | 124,76 | 124,76 | 115,94 | 116,13 | -6,72% | 7,07% | 502.200 |
| 23/10/2018 | 120,79 | 125,66 | 118,53 | 124,49 | +1,82% | 5,90% | 406.900 |
| 22/10/2018 | 123,94 | 125,24 | 120,79 | 122,27 | -0,55% | 3,59% | 318.900 |
| 19/10/2018 | 126,54 | 127,86 | 122,53 | 122,95 | -2,29% | 4,21% | 320.100 |
| 18/10/2018 | 127,39 | 128,18 | 125,46 | 125,83 | -0,92% | 2,14% | 344.700 |
| 17/10/2018 | 127,46 | 128,55 | 126,17 | 127,00 | -0,03% | 1,87% | 362.700 |
| 16/10/2018 | 124,05 | 127,11 | 123,61 | 127,04 | +2,93% | 2,82% | 279.400 |
| 15/10/2018 | 123,36 | 125,13 | 122,82 | 123,42 | +0,25% | 1,87% | 265.200 |
| 12/10/2018 | 122,35 | 125,04 | 120,39 | 123,11 | +1,43% | 3,80% | 426.900 |
| 11/10/2018 | 124,42 | 127,05 | 121,23 | 121,38 | -2,08% | 4,68% | 357.300 |
| 10/10/2018 | 125,10 | 126,90 | 123,67 | 123,96 | -0,97% | 2,58% | 232.500 |
| 09/10/2018 | 126,83 | 127,00 | 124,67 | 125,17 | -1,17% | 1,84% | 247.400 |
| 08/10/2018 | 125,00 | 127,44 | 123,17 | 126,65 | +1,43% | 3,42% | 258.000 |
| 05/10/2018 | 125,59 | 127,68 | 123,42 | 124,87 | -0,19% | 3,39% | 267.000 |
| 04/10/2018 | 128,16 | 128,68 | 124,35 | 125,11 | -2,81% | 3,38% | 357.200 |
| 03/10/2018 | 127,14 | 129,59 | 125,15 | 128,73 | +2,08% | 3,49% | 315.600 |
| 02/10/2018 | 126,30 | 127,14 | 124,53 | 126,11 | +0,12% | 2,07% | 266.300 |
| 01/10/2018 | 128,41 | 128,41 | 125,35 | 125,96 | -1,50% | 2,38% | 301.700 |
| 28/09/2018 | 125,60 | 129,00 | 125,47 | 127,88 | +1,19% | 2,81% | 558.000 |
| 27/09/2018 | 125,20 | 127,43 | 124,03 | 126,37 | +0,88% | 2,72% | 264.600 |
| 26/09/2018 | 125,46 | 127,79 | 123,93 | 125,27 | -0,19% | 3,08% | 404.600 |
| 25/09/2018 | 126,27 | 126,75 | 124,57 | 125,51 | +0,15% | 1,73% | 328.100 |
| 24/09/2018 | 122,95 | 125,79 | 122,35 | 125,32 | +2,10% | 2,80% | 214.900 |